JM

John Miller

Senior Vice President, Corporate Strategy

Jazz Pharmaceuticals

Jazz Pharmaceuticals Pipeline

DrugIndicationPhase
VyxeosAcute Myeloid LeukemiaCommercial
DefitelioHepatic Veno-Occlusive DiseaseCommercial
SunosiNarcolepsy and Idiopathic HypersomniaCommercial
EpidiolexRare EpilepsiesCommercial
Oncology Pipeline ProgramsVarious Cancer TypesPre-clinical/Clinical